Eeshal Fatima

ORCID: 0009-0004-7103-9364
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Breast Cancer Therapies
  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Prostate Cancer Treatment and Research
  • Cancer Treatment and Pharmacology
  • Heart Failure Treatment and Management
  • Colorectal Cancer Screening and Detection
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cancer Immunotherapy and Biomarkers
  • HER2/EGFR in Cancer Research
  • Cardiac tumors and thrombi
  • Radiomics and Machine Learning in Medical Imaging
  • Metastasis and carcinoma case studies
  • Diverse Scientific Research Studies
  • Infectious Diseases and Tuberculosis
  • Blood Pressure and Hypertension Studies
  • Chronic Lymphocytic Leukemia Research
  • Peptidase Inhibition and Analysis
  • Health Systems, Economic Evaluations, Quality of Life
  • Global Cancer Incidence and Screening
  • Neuroendocrine Tumor Research Advances
  • Lipoproteins and Cardiovascular Health
  • PARP inhibition in cancer therapy
  • Lung Cancer Research Studies
  • Chronic Disease Management Strategies

Services Institute of Medical Sciences
2023-2025

University College Lahore
2024

Allama Iqbal Medical College
2024

Sir Ganga Ram Hospital
2024

Johns Hopkins University
2024

King Edward Medical University
2024

Methodist Hospital
2024

Université Officielle de Bukavu
2023

Devon Partnership NHS Trust
2017

Abstract Background and Aims Artificial intelligence (AI) has emerged as a transformative force in laboratory medicine, promising significant advancements healthcare delivery. This study explores the potential impact of AI on diagnostics patient management within context with particular focus low‐ middle‐income countries (LMICs). Methods In writing this article, we conducted thorough search databases such PubMed, ResearchGate, Web Science, Scopus, Google Scholar 20 years. The examines AI's...

10.1002/hsr2.1794 article EN cc-by Health Science Reports 2024-01-01

29 Background: The American Cancer Society estimated that 1.9 million new cancer cases were identified in 2021, comprising 260,210 newly diagnosed male genital neoplasm cases. Prostate is considered the second leading cause of cancer-related mortality among men United States (US). Cardiovascular events are commonly observed patients receiving androgen deprivation therapy or platinum-based chemotherapy, fundamental treatments for malignant reproductive organ tumors. Therefore, objective our...

10.1200/jco.2025.43.5_suppl.29 article EN Journal of Clinical Oncology 2025-02-10

Immune checkpoint inhibitors (ICI) upregulate host antitumor immunity, proving efficacy across diverse tumor types. Currently approved ICI treatment primarily targets the programmed cell death receptor 1 (PD-1) and its ligand PD-L1, cytotoxic T lymphocyte-antigen 4 (CTLA-4). Nivolumab is a monoclonal antibody that human PD-1 an entirely immunoglobulin G4 (IgG4), by FDA for various cancers like advanced melanoma, metastatic renal carcinoma, Hodgkin lymphoma, lung carcinoma. This review will...

10.1097/coc.0000000000001166 article EN American Journal of Clinical Oncology 2025-02-26

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and leads to serious complications if left untreated. Some strains of are multi-drug resistant require treatment with newer drugs. Bedaquiline based regimens have been used in patients who diagnosed drug tuberculosis. The aim this study assess the efficacy safety profile bedaquiline-based using a systematic review existing literature meta-analysis.In study, electronic search was carried out on PubMed, ScienceDirect,...

10.1016/j.jctube.2023.100405 article EN cc-by Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2023-12-01
Coming Soon ...